WinstonWınston
Orthometrix logo

Orthometrix

OMRX
32
Medical - Specialties · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$4,699
Winston Score
32
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+19.5% over 8y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 44.5M (2006) → 53.2M (2014)

Orthometrix is a small medical device company that sells equipment used to treat bone and soft tissue conditions without surgery. Its main product is the Hivamat, a device that uses electrical fields to reduce pain and swelling — used by physical therapists, sports medicine clinics, and rehabilitation centers. The company distributes medical devices primarily in the United States.

Orthometrix makes money by selling and leasing its devices directly to healthcare providers, and it earns additional revenue from related accessories and supplies. It is a very small company with a market cap under $10 million, but its high gross margins and strong return on invested capital suggest it holds a niche position in its narrow product category. The key risk is its tiny size — it has limited resources to expand its sales force, fund new product development, or compete if a larger medical device company targets the same market.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-82.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-212.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

74.4%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$2,332 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Orthometrix has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
9.7%
Thin — 9.7% gross margin
Operating Margin
184.6%
Excellent — 184.6% operating margin
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-29.6%
Shrinking sales (-29.6% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-39.3%
Burning cash (-39.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
2.17x
Tight — interest eats into profit (2.2x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.0x
Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial